Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1AAV1-gamma-sarcoglycan vector injection----1件: 113
2Alirocumab SAR236553 (REGN727)1件: Alirocumab1件: D10335 1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79
3Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab4件: Abatacept,
Rituximab,
Sarilumab,
Tocilizumab		4件: D02596 ,
D02994 ,
D03203 ,
D10161 (Name: Sarilumab)		4件: CD80,
CD86,
IL6R,
MS4A1 💬		25件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬1件: 46
4GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)1件: Sargramostim1件: D05803 (Name: Sargramostim)1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229
5GM-CSF [Leukine (Sargramostim)]1件: Sargramostim1件: D05803 (Name: Sargramostim)1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229
6GZ/SAR402671----2件: 19, 67
7GZ402671 / SAR402671----1件: 19
8Isatuximab
(Synonym: Sarclisa (TN))		1件: Isatuximab (Synonym: Sarclisa)1件: D11050 (Name: Sarclisa (TN))1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬3件: 28, 61, 283
9Isatuximab SAR6509841件: Isatuximab (Synonym: Sarclisa)1件: D11050 (Name: Sarclisa (TN))1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬1件: 61
10Lademirsen (SAR339375)----1件: 218
11Long term follow up in all patients who received SAR422459 in previous study TDU13583----1件: 301
12RAAV1.tMCK.human-alpha-sarcoglycan- First cohort----1件: 113
13RAAV1.tMCK.human-alpha-sarcoglycan- Second cohort----1件: 113
14REGN475/SAR164877----1件: 298
15Sar----1件: 46
16SAR100842----2件: 51, 85
17SAR113244----1件: 49
18SAR1531911件: Sarilumab1件: D10161 (Name: Sarilumab)1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬4件: 41, 46, 107, 271
19SAR153191 (REGN88)1件: Sarilumab1件: D10161 (Name: Sarilumab)1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107
20SAR156597----2件: 51, 85
21SAR231893----2件: 51, 160
22SAR236553----1件: 79
23SAR339375----1件: 218
24SAR339658----2件: 13, 97
25SAR402671, GZ402671 o GZ/SAR402671----2件: 19, 67
26SAR402671, GZ402671 or GZ / SAR402671----1件: 19
27SAR402671, GZ402671 or GZ/SAR402671----3件: 6, 19, 67
28SAR421869----2件: 90, 303
29SAR422459----1件: 301
30SAR439459----1件: 274
31SAR441344----3件: 13, 49, 53
32SAR441344 IV----2件: 13, 49
33SAR441344 SC----2件: 13, 49
34SAR442168----2件: 11, 13
35SAR443122----1件: 97
36SAR443820----2件: 2, 13
37SAR444671----1件: 61
38SAR445088----1件: 61
39SAR445088 (formerly BIVV020)----1件: 14
40SAR445088 (IV)----1件: 14
41SAR445088 (SC)----1件: 14
42SAR650984----1件: 61
43Saracatinab----1件: 85
44Saracatinib1件: Saracatinib1件: D09664 (Name: Saracatinib)2件: ABL1,
SRC 💬		49件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬3件: 6, 89, 272
45SARACATINIB DIFUMARATE1件: Saracatinib1件: D09664 (Name: Saracatinib)2件: ABL1,
SRC 💬		49件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬1件: 272
46Sarcosine1件: Sarcosine---1件: 6
47Sarcosine Capsule1件: Sarcosine---1件: 6
48Sargramostim1件: Sargramostim1件: D05803 (Name: Sargramostim)1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬7件: 6, 28, 60, 62, 96, 229, 285
49Sargramostim (Leukine)1件: Sargramostim1件: D05803 (Name: Sargramostim)1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 96
50SARILUMAB1件: Sarilumab1件: D10161 (Name: Sarilumab)1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬5件: 41, 46, 84, 107, 271
51Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]1件: Sarilumab1件: D10161 (Name: Sarilumab)1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
52Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#11件: Sarilumab1件: D10161 (Name: Sarilumab)1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 84
53Sarilumab SAR1531911件: Sarilumab1件: D10161 (Name: Sarilumab)1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 41
54Sarilumab SAR153191 (REGN88)1件: Sarilumab1件: D10161 (Name: Sarilumab)1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107
55SARIZOTAN1件: Sarizotan---2件: 6, 156
56Sarizotan HC11件: Sarizotan---1件: 6
57Sarizotan HCl1件: Sarizotan---1件: 6
58Sarizotan Hydrochloride1件: Sarizotan---2件: 6, 156
59Saroglitazar1件: Saroglitazar---1件: 93
60SAROGLITAZAR MAGNESIUM2件: Magnesium,
Saroglitazar		---1件: 93
61Saroglitazar Magnesium 1 mg2件: Magnesium,
Saroglitazar		---1件: 93
62Saroglitazar Magnesium 2 mg2件: Magnesium,
Saroglitazar		---1件: 93
63Saroglitazar magnesium 4 mg2件: Magnesium,
Saroglitazar		---1件: 93
64SARS-COV-2 mRNA Vaccine1件: CVnCoV (Synonym: SARS-CoV-2 mRNA vaccine)---1件: 13
65UshStat (SAR421869)----2件: 90, 303
66Venglustat GZ/SAR4026711件: Venglustat1件: D11633 1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬2件: 6, 67
67Volixibat (formely SHP626, LUM002 or SAR548304B)1件: Volixibat1件: D11007 --1件: 94